Safety of colonoscopic therapy under continuance of warfarin

Safety of colonoscopic therapy under continuance of warfarin - Safety of colonoscopic therapy with warfarin

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019595

Enrollment

Registered

2015-11-09

Start date

2016-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal polyp

Interventions

Endoscopic threpy of colorectal polyps for patients with warfarin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases with warfarin for thromboembolism

Exclusion criteria

Exclusion criteria: Cases with main organ dysfunction

Design outcomes

Primary

Measure	Time frame
The rate of postoperative hemorrhage until 4 months after intervention.	—

Secondary

Measure	Time frame
The rate of moderate-severe perioperative hemorrhage The rate of thromboembolism The change of PT-INR	—

Countries

Japan

Contacts

Public ContactNaohisa Yoshida

Kyoto Prefectural University of Medicine Department of Molecular Gastroenterology and Hepatology

naohisa@koto.kpu-m.ac.jp075-251-5519

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026